Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Correspondence: T Dosani, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, ...
However, inflammation is a complicated process involving many different types of cells from our immune system working together. This has made it ...
“I thought that the human immune system is really our best defense against cancer,” said in a press release study author Brunhilde “Brunie” Felding.
“This is exciting because we have found a completely different way to use the immune system to fight cancer,” said Professor Philip Ashton-Rickardt, ...
According to the World Health Organization, breast cancer is the most common ... The study found that while the exact role of immune system cells was ...
Angiogenesis inhibitors—a widely used class of cancer drugs designed to shrink ... Working with laboratory models of pancreatic and breast cancer, the ... first-line of defense—the so-called “innate” immune system—at first work in ...
Cancer genomics researcher Timothy Chan Genomics researcher Timothy Chan was surprised to discover that lung tumors with a lot of ...
“MicroVAX is of the vision that immunotherapy will be key for cancer therapy going ... The pioneer of immunotherapy can be traced back to the 1890s.
Marking an important step in the development of immunotherapy cancer treatment, scientists have demonstrated that nanoparticle-coated bacteria can ...
AstraZeneca's MedImmune is expanding its alliance with private UK biotech Immunocore to carry out combination immunotherapy trials in skin cancer.
“We are eagerly looking forward to the initiation of this trial of Pexa-Vec in patients with incurable liver cancer.Cancer immunotherapy is making a ...
Sidra Medical and Research Center (Sidra) hosted the first conference on breast cancer immunotherapy. The two-day event, organised by Sidra and ...
(Bloomberg) -- Roche Holding AG will skip a mid-stage study of an experimental immunotherapy for breast cancer and proceed directly to a phase 3 ...
and could be tested on humans in three years
Treatment developed by British team could boost ability to fight cancer
Imperial College London say human trials of therapy could begin in 3 years
Protein discovered could boost immune system ten times to fight cancer
The chance discovery made when unknown molecule was found in mice
For example, we tested this on a patient who had bladder cancer. It was a very aggressive cancer, which failed to respond to all other therapies.
... (EValuating OncoLytic Vaccine Efficacy) trial has expanded to include repeat intravenous dosing of EnAd in metastatic urothelial bladder cancer.
Development of predictive value of urinary cytokine profile induced during intravesical Bacillus ...
Development of predictive value of urinary cytokine profile induced during intravesical Bacillus Calmette-Guérin instillations for bladder cancer - ...
An MRI screening program for individuals at high risk for pancreatic cancer may be effective, according to the results of a short-term study from ...
Two posters will show data supporting further biomarker-driven clinical development of BNC101 in pancreatic cancer and solid tumors. BNC101 is a ...
Patients with muscle-invasive bladder cancer who received neoadjuvant gemcitabine plus cisplatin (GC) and methotrexate, vinblastine, doxorubicin, ...
Years of prior research in Lokeshwar's laboratory found that the HA family of molecules promotes prostate and bladder cancer cell growth, their ...
... required to get a clinical trial application by Health Canada to start enrolling patients for a very deadly disease, non-muscle invasive bladder cancer.
Optimal Post-Treatment Surveillance in Cancer Survivors: Is More Really Better?
In this review, we discuss the established guidelines and current evidence regarding post-treatment surveillance, and we propose general management strategies in prostate, colorectal, and breast cancers.
In this review, we discuss the established guidelines and current evidence regarding post-treatment surveillance, and we propose general management strategies in prostate, colorectal, and breast cancers.
Caring for the Life You Saved
We may find that in the case of recurrence surveillance, doing less than we now do is better. Conversely, for persistent symptoms, adoption of lifestyle behaviors by survivors, and the meeting of family needs, doing more than we do now is better.
We may find that in the case of recurrence surveillance, doing less than we now do is better. Conversely, for persistent symptoms, adoption of lifestyle behaviors by survivors, and the meeting of family needs, doing more than we do now is better.
Surviving Surveillance
The message seems to be emerging that for some diseases, clinical monitoring for relapse and recurrence has a strong evidence base, is safe, and is associated with lower costs.
The message seems to be emerging that for some diseases, clinical monitoring for relapse and recurrence has a strong evidence base, is safe, and is associated with lower costs.
Fish Oil Consumption Linked to Chemoresistance
A new study has shown that consumption of fish oil can raise the plasma levels of fatty acids, which may cause resistance to chemotherapy for cancer treatment.
A new study has shown that consumption of fish oil can raise the plasma levels of fatty acids, which may cause resistance to chemotherapy for cancer treatment.
Vaccinating Boys Against HPV Proves Cost-Effective
Vaccinating boys aged 12 years against the human papillomavirus (HPV) may be cost-effective in the prevention of oropharyngeal cancer.
Vaccinating boys aged 12 years against the human papillomavirus (HPV) may be cost-effective in the prevention of oropharyngeal cancer.
Urine Test Detects Early-Stage Renal Cell Carcinoma
Researchers at Washington University School of Medicine in St. Louis, have developed a new test that detects two proteins in urine that indicate the presence of early-stage kidney cancers.
Researchers at Washington University School of Medicine in St. Louis, have developed a new test that detects two proteins in urine that indicate the presence of early-stage kidney cancers.
Science Daily Cancer News
Obesity in black men substantially increases the risk of low- and high-grade prostate cancer, while obesity in white men moderately reduces the risk of low-grade cancer and only slightly increases the risk of high-grade cancer, according to the first large, prospective study to examine how race and obesity jointly affect prostate cancer risk.
A new method for measuring genetic variability within a tumor might one day help doctors identify patients with aggressive cancers that are more likely to resist therapy, according to a study. Researchers used a new scoring method they developed called MATH (mutant-allele tumor heterogeneity) to measure the genetic variability among cancer cells within tumors from 305 patients with head and neck cancer. High MATH scores corresponded to tumors with many differences among the gene mutations present in different cancer cells.
Scientists have discovered a protein that plays a central role in promoting immunity to viruses and cancer, opening the door to new therapies. Experiments in mice and human cells have shown that the protein promotes the proliferation of cytotoxic T cells, which kill cancer cells and cells infected with viruses. The discovery was unexpected because the new protein had no known function and doesn’t resemble any other protein.
Researchers describe a new way that cancer cells invade other parts of the body, identifying a new treatment target that may be more effective than current drugs. "We are looking for novel ways of preventing cancer cells of the primary tumor from spreading to other parts of the body. Our study points to potential therapeutic targets that could be inhibited to halt tumor cell movement," says the study's principal investigator.
Zinc deficiency -- long associated with numerous diseases, e.g., autism, lung cancer, prostate cancer, and ovarian cancers -- can lead to activation of the Hedgehog signaling pathway, a biomolecular pathway that plays essential roles in developing organisms and in diseases, according to new research.
People with limited education and low income have higher odds of death within 30 days after undergoing an operation for lung cancer than those who are more educated and financially better off, according to new research.
Could a mushroom a day help keep the doctor away? Some early evidence indicates that the Shiitake mushroom boosts immunity. Of the thousands of mushroom species globally, about 20 are used for culinary purposes. Shiitake mushrooms are native to Asia and are cultivated for their culinary and medicinal value.
Walking at an easy pace for about three hours every week may be just enough physical activity to help prostate cancer survivors reduce damaging side effects of their treatment, according to a new study. "Non-vigorous walking for three hours per week seems to improve the fatigue, depression and body weight issues that affect many men post-treatment," said the lead author of the study. "If you walk even more briskly, for only 90 minutes a week, you could also see similar benefits in these areas."
Almost weekly, a new synthetic psychoactive drug comes onto the market that can be ordered legally and easily, for example as an incense blend, via the Internet. Synthetic cannabinoids are difficult to identify chemically and the possible unwanted toxic effects that can occur following their consumption have so far barely been investigated. As part of the international EU project "SPICE II Plus", researchers have now also found evidence that synthetic substances damage the DNA of human cells and can therefore possibly have cancer-causing effects.
With the advent of targeted lymphoma therapies on the horizon, it becomes increasingly important to differentiate the two major subtypes of diffuse large B-cell lymphoma (DLBCL), which is the most common non-Hodgkin lymphoma. These are germinal center B-cell-like (GCB) and activated B-cell-like (ABC), which differ in management and outcomes. A report describes use of the reverse transcriptase multiplex ligation-dependent probe amplification (RT-MLPA) assay for differentiating DLBCL subtypes. RT-MLPA is as accurate as the current gold standard technology and offers advantages such as simplicity, flexibility, short turnaround time, low cost, and efficiency.
Tambahkan Komentar